Tech Company Financing Transactions
Regentis Biomaterials Funding Round
Regentis Biomaterials, based in Or-Akiva, secured $7.5 million from private investors.
Transaction Overview
Company Name
Announced On
8/16/2007
Transaction Type
Venture Equity
Amount
$7,500,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
12 Ha'ilan St. Northern Industrial Zone P.O.Box 260
Or-Akiva, 3060000
Israel
Or-Akiva, 3060000
Israel
Phone
Website
Email Address
Overview
Regentis Biomaterials is a medical material development company that is focused on commercializing its patent-applied Gelrin Platform Technology for bone, spine and cartilage repair.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Alastair Clemow
Chief Scientific Officer
Dror Seliktar
General Manager
Livnat Ben-Zur
VP - R & D
Roni Wechsler
VP - Regulatory Affairs
Brooke Mastrorio
Browse more venture capital transactions:
Prev: 8/16/2007: Kongregate venture capital transaction
Next: 8/16/2007: PlumChoice venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. VC transactions reported here are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs